Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference22 articles.
1. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment;Avery;Retina,2006
2. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up;Arevalo;Retina,2008
3. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study;Bashshur;Am. J. Ophthalmol.,2008
4. Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals;Barar;Bioimpacts,2013
5. Vascular leukocytes contribute to tumor vascularization;Conejo-Garcia;Blood,2005
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in targeted nano-delivery of bevacizumab using nanoparticles: Current insights, innovations, and future perspectives;Journal of Drug Delivery Science and Technology;2024-09
2. Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer;International Journal of Molecular Sciences;2024-07-30
3. Emerging applications of anti-angiogenic nanomaterials in oncotherapy;Journal of Controlled Release;2023-12
4. Design of Ultrasmall Silica Nanoparticles for Versatile Biomedical Application in Oncology: A Review;Nano Biomedicine and Engineering;2023-12
5. Combinatorial treatment using bevacizumab/pemetrexed loaded core-shell silica nanoparticles for non-small cell lung cancer;Science and Technology of Advanced Materials;2023-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3